Company Description
Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than sixty-five products sold by customers worldwide.
Company Background
- 40+ years of experience
- 750 global employees
- 96% customer satisfaction rating
- 70+ contract development projects
- 65+ commercial products globally
- Headquartered in Philadelphia, PA
- Manufacturing and/or R&D facilities in the US & EU
Facilities
Adare operates facilities in the US and Europe, staffed by over 750 employees. With a global manufacturing network, Adare offers integrated global and regional supply chains from state-of-the-art facilities in the US and Europe. We deliver development-scale through commercial-scale production, with a continuum of highly specialized manufacturing services and capabilities to meet any customer’s oral solid dose needs.
Services and Capabilities
Adare Pharma Solutions provides comprehensive CDMO services, from the earliest stages of development to commercial manufacturing and packaging for both new and existing products, with expertise in complex formulations and patient-centric technologies.
Adare’s industry-leading experts possess unparalleled experience in the development of unique dosage forms that provide taste masking, customized release, and patient-centric solutions. Our technology platforms overcome complex formulation challenges to improve the lives of all patients, with expertise in pediatric, geriatric, and dysphagic requirements.